Cargando…
A randomized clinical trial to evaluate the effects of rasagiline on depressive symptoms in non-demented Parkinson’s disease patients
BACKGROUND AND PURPOSE: Depressed mood is a common psychiatric problem associated with Parkinson’s disease (PD), and studies have suggested a benefit of rasagiline treatment. METHODS: ACCORDO (see the 1) was a 12-week, double-blind, placebo-controlled trial to evaluate the effects of rasagiline 1 mg...
Autores principales: | Barone, P, Santangelo, G, Morgante, L, Onofrj, M, Meco, G, Abbruzzese, G, Bonuccelli, U, Cossu, G, Pezzoli, G, Stanzione, P, Lopiano, L, Antonini, A, Tinazzi, M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4676931/ https://www.ncbi.nlm.nih.gov/pubmed/25962410 http://dx.doi.org/10.1111/ene.12724 |
Ejemplares similares
-
COMT inhibition with tolcapone in the treatment algorithm of patients with Parkinson’s disease (PD): relevance for motor and non-motor features
por: Antonini, Angelo, et al.
Publicado: (2008) -
Rasagiline in treatment of Parkinson’s disease
por: Nayak, Lakshmi, et al.
Publicado: (2008) -
The role of rasagiline in the treatment of Parkinson’s disease
por: Leegwater-Kim, Julie, et al.
Publicado: (2010) -
Rasagiline Withdrawal Syndrome in Parkinson’s Disease
por: Solla, Paolo, et al.
Publicado: (2022) -
Risk factors for impulse control disorders and related behaviors in Parkinson’s disease: secondary analyses of the ICARUS study
por: Barone, Paolo, et al.
Publicado: (2019)